- Correlation of HER-2 expression in tumour tissue with serum levels of breath carcinoma patientsPublication without faculty affiliation
- The role of hormonal and antiHER-2 therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER-22010 | First Faculty of Medicine
- Therapeutic significance of hormone receptor positivity in patients with her-2 positive breast cancer2019 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- A modified approach for I-FISH evaluation of ERBB2 (HER-2) gene copy numbers in breast carcinomas: comparison with HER-2/CEP17 ratio system2007 | Second Faculty of Medicine
- HER-2 tissue expression correlated with serum levels in breast cancer patients2007 | First Faculty of Medicine
- Retreatment with trastuzumab in HER-2 positive metastatic breast cancer progressing after trastuzumab and lapatinib2012 | First Faculty of Medicine
- Clinical importance of her-3 in breast cancer2020 | First Faculty of Medicine, Third Faculty of Medicine
- Treatment of triple-positive breast cancer2010 | First Faculty of Medicine
- HER-3 molecular classification, expression of PD-L1 and clinical importance in breast cancer2022 | First Faculty of Medicine, Third Faculty of Medicine
- Controversies of radiotherapy in human epidermal growth factor receptor (HER)-2 positive breast cancer patients2021 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Pharmacological profile – trastuzumab emtansine2022 | Third Faculty of Medicine
- New Trends in Diagnostics and Classification of Breast Carcinoma +12009 | Faculty of Medicine in Hradec Králové
- New Trends in Diagnostics and Classification of Breast Carcinoma2009 | First Faculty of Medicine
- Prognostic significance of increased urinary neopterin concentrations in patients with breast carcinoma2011 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Molecular predictive factors of outcome of radiotherapy in cervical cancer2011 | Faculty of Medicine in Hradec Králové
- Tamoxifen and QT interval +12008 | Faculty of Medicine in Hradec Králové
- Tamoxifen and QT interval2008 | First Faculty of Medicine
- Effect of neoadjuvant Herceptin (trastuzumab) in a patient with breast cancer with high growth activity2009 | First Faculty of Medicine
- Prognostic and predictive factors of breast cancer in clinical practice2012 | Faculty of Medicine in Pilsen
- Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase 2 trial2006 | First Faculty of Medicine
- Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase 2 trial2006 | Faculty of Physical Education and Sport
- Tamoxifen-induced QT interval prolongation +12008 | Faculty of Medicine in Hradec Králové
- Tamoxifen-induced QT interval prolongation2008 | First Faculty of Medicine
- Increased efficacy of a dose-dense regimen of neoadjuvant chemotherapy in breast carcinoma: a retrospective analysis2012 | Faculty of Medicine in Hradec Králové
- Tamoxifen Induced QT Interval Prolongation: A case report +12008 | Faculty of Medicine in Hradec Králové
- Tamoxifen Induced QT Interval Prolongation: A case report2008 | First Faculty of Medicine
